YAP1 and diabetic cardiomyopathy: The knockdown of MALAT1 in the diabetic cardiomyopathy mice model alleviates the clinical manifestations of high glucose on heart muscles, such as inflammation and collagen accumulation, by influencing the Hippo-Yap pathway [60].